• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.

    7/13/26 7:47:39 AM ET
    $BYAH
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $BYAH alert in real time by email
    6-K 1 ea0297801-6k_parkha.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of July 2026

     

    Commission File Number: 001-42453

     

    Park Ha Biological Technology Co., Ltd.

     

    901 & 901-2, Building C

    Phase 2, Wuxi International Life Science Innovation Campus

    196 Jinghui East Road

    Xinwu District, Wuxi, Jiangsu Province

    People’s Republic of China 214000

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F ☒        Form 40-F ☐

     

     

     

     

     

     

    POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING AND CLASS A MEETING HELD
    ON JULY 13, 2026

     

    References are made to the Notice of the Extraordinary General Meeting (the “EGM”) and the Notice of Class A Meeting (the “Class A Meeting”), each dated July 6, 2026 (collectively, the “Notices”) of Park Ha Biological Technology Co., Ltd. (the “Company”). Unless otherwise required by the context, capitalized terms used in this announcement shall have the same meanings as defined in the Notices. In addition, holders of Class B Ordinary Shares acted by written resolution in lieu of a separate class meeting.

     

    POLL RESULTS OF THE EGM AND THE CLASS A MEETING

     

    Poll results of the EGM

     

    The EGM was held at 901 & 901-2, Building C Phase 2, Wuxi International Life Science Innovation Campus, 196 Jinghui East Road, Xinwu District, Wuxi, Jiangsu Province People’s Republic of China on July 13, 2026 at 10:30 A.M. (local time).

     

    As of the close of business on July 2, 2026 (the “Record Date”), the total number of issued Shares was 6,364,216 Shares, comprising 5,983,216 Class A Ordinary Shares and 381,000 Class B Ordinary Shares, which was the total number of Shares entitling Shareholders to attend and vote in favor of, against or in abstention on the resolutions proposed at the EGM. Each Class A Ordinary Share is entitled to one (1) vote and each Class B Ordinary Share is entitled to twenty (20) votes. Holders of 2,685,079.13 Class A Ordinary Shares and holders of 381,000 Class B Ordinary Shares issued and outstanding voted at the EGM in person or by proxy, representing approximately 75.76% of the total voting power shares voted.

     

    As a result, holders representing not less than 30% of the total voting power of the Company’s Class A Ordinary Shares and Class B Ordinary Shares, entitled to vote at the EGM, were present in person or by proxy, and a quorum was therefore present for the transaction of business at the EGM.

     

    All resolutions proposed at the EGM have been duly passed. The voting results in respect of the resolutions proposed at the EGM are set out as follows:

     

    1. RESOLVED AS AN ORDINARY RESOLUTION THAT:

     

    The authorised share capital of the Company is increased from US$3,000,000.00 divided into 3,000,000,000 ordinary shares of par value US$0.001 each, comprising 2,400,000,000 Class A Ordinary Shares and 600,000,000 Class B Ordinary Shares, to US$300,000,000 by creating additional 297,000,000,000 ordinary shares of par value US$ 0.001 each to rank pari passu in all respects with the existing shares in the capital of the Company such that the Company is authorised to issue 300,000,000,000 ordinary shares of par value US$0.001 each, comprising 240,000,000,000 Class A Ordinary Shares and 60,000,000,000 Class B Ordinary Shares.

     

    For  Against  Abstain
    10,283,040.21  22,038.92  0

     

    2. RESOLVED AS AN ORDINARY RESOLUTION THAT:

     

    The Board is hereby authorised, in its sole discretion, to effect one or more consolidations of all of the Company’s authorised, issued and outstanding Class A Ordinary Shares and Class B Ordinary Shares at any time during the three (3)-year period following the date of the Extraordinary General Meeting, with the exact consolidation ratio and effective time to be determined by the Board in its sole discretion, provided that the aggregate consolidation ratio resulting from any and all such share consolidations shall not be less than 2-for-1 nor greater than 5,000-for-1, and that the consolidated shares shall have the same rights and be subject to the same restrictions (other than any adjustment to par value) as the corresponding shares immediately prior to such share consolidation under the Company’s then effective Amended and Restated Memorandum and Articles of Association.

     

    For  Against  Abstain
    10,282,738.21  22,330.90  10.02

     

    3. RESOLVED AS AN ORDINARY RESOLUTION THAT:

     

    The Board is hereby authorised, in its sole discretion, to effect one or more subdivisions of all of the Company’s authorised, issued and outstanding Class A Ordinary Shares and Class B Ordinary Shares at any time during the three (3)-year period following the date of the Extraordinary General Meeting, with the exact subdivision ratio and effective time to be determined by the Board in its sole discretion, provided that the aggregate subdivision ratio resulting from any and all such share subdivisions shall not be less than 2-for-1 nor greater than 100-for-1, and that the subdivided shares shall have the same rights and be subject to the same restrictions (other than any adjustment to par value) as the corresponding shares immediately prior to such share subdivision under the Company’s then effective Amended and Restated Memorandum and Articles of Association.

     

    For  Against  Abstain
    10,282,914.92  22,160.92  3.29

     

    1

     

     

    4. RESOLVED AS A SPECIAL RESOLUTION THAT:

     

    Subject to the approval of Proposal No.1 and the separate approvals by the holders of the Class A Ordinary Shares and Class B Ordinary Shares in accordance with the Company’s existing amended and restated memorandum and articles of association, the Amended and Restated Memorandum and Articles of Association in the form produced to the Meeting and attached as Appendix 1 to the Notice of Extraordinary General Meeting are adopted, in substitution for, and to the exclusion of, the Company’s existing Amended and Restated Memorandum and Articles of Association.

     

    For  Against  Abstain
    10,282,737.22  22,061.91  280.00

     

    The approval of Proposal No. 4 shall be conditional upon the passing of a special resolution by each of (i) the holders of Class A Ordinary Shares at the Class A Meeting, and (ii) the holders of Class B Ordinary Shares by written resolution.

     

    Poll results of the Class A Meeting

     

    The Class A Meeting was held at 901 & 901-2, Building C Phase 2, Wuxi International Life Science Innovation Campus, 196 Jinghui East Road, Xinwu District, Wuxi, Jiangsu Province People’s Republic of China on July 13, 2026 at 11:00 A.M. (local time).

     

    As of the Record Date, the Company had a total of 5,983,216 Class A Ordinary Shares in issue, representing the total number of shares entitled to vote on the resolution proposed at the Class A Meeting. Holders of 2,685,079.13 Class A Ordinary Shares (approximately 44.88% of the shares entitled to vote) voted in person or by proxy at the Class A Meeting.

     

    As a result, holders representing not less than one-third of the total voting power of the Company’s Class A Ordinary Shares, entitled to vote at the Class A Meeting, were present in person or by proxy, and a quorum was therefore present for the transaction of business at the Class A Meeting.

     

    The special resolution proposed at the Class A Meeting has been duly passed. The voting results in respect of the special resolution proposed at the Class A Meeting are set out as below:

     

    1. RESOLVED AS A SPECIAL RESOLUTION THAT:

     

    The voting rights attaching to each Class B Ordinary Share are increased from 20 (twenty) votes to 100 (one hundred) votes for each Class B Ordinary Share of which he is the holder.

     

    For  Against  Abstain
    2,662,726.92  22,343.92  8.29

     

    Results of the Class B Written Resolution

     

    In lieu of a separate class meeting of holders of Class B Ordinary Shares, the sole holder of Class B Ordinary Shares acted by written resolution. As of the Record Date, there were 381,000 Class B Ordinary Shares outstanding. The sole holder of Class B Ordinary Shares, representing 381,000 Class B Ordinary Shares (or 100% of the issued Class B Ordinary Shares), approved by written resolution. The special resolution proposed sets out as follows:

     

    1. RESOLVED AS A SPECIAL RESOLUTION THAT:

     

    In accordance with Article 6.2(b) of the Company's existing amended and restated memorandum and articles of association, that the variation of the rights attaching to Class B Ordinary Shares resulting from the number of votes holders of Class B Ordinary Share are entitled to cast on a poll being increased from 20 votes to 100 votes for each Class B Ordinary Share she holds is approved.

     

    CONCLUSION

     

    All resolutions proposed at the EGM and the Class A Meeting have been duly passed, and the written resolution of the holder of Class B Ordinary Shares has been duly executed and returned. Accordingly, all of the proposals described in the Notices have been approved by the requisite majorities of the shareholders of the Company.

     

    2

     

     

    EXHIBIT INDEX

     

    The following exhibit is being filed herewith:

     

    Exhibit No.   Description
    99.1   Form of Amended and Restated Memorandum and Articles of Association

     

    3

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Park Ha Biological Technology Co., Ltd.
         
    Date: July 13, 2026 By: /s/ Xiaoqiu Zhang
      Name:  Xiaoqiu Zhang
      Title: Chief Executive Officer, Chairperson of the Board of Directors

     

    4

    Get the next $BYAH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BYAH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BYAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Shan Yanan

    3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)

    4/7/26 8:28:54 AM ET
    $BYAH
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 3 filed by new insider Li Xinyu

    3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)

    4/7/26 8:27:51 AM ET
    $BYAH
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 3 filed by new insider Yu Xiaozhong

    3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)

    4/7/26 8:26:39 AM ET
    $BYAH
    Package Goods/Cosmetics
    Consumer Discretionary

    $BYAH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Park Ha Biological Technology Co., Ltd. Announces Official Approval of Its North American Amazon Store, Launching a New Era of Brand Globalization

    Wuxi, China, July 06, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) ("Park Ha Biological" or the "Company") announced that it has successfully passed the comprehensive and rigorous process to open a store on Amazon North America, and the cross-border store has been officially approved for opening and all registration procedures have been completed. This successful entry represents a critical milestone in the execution of the Company's global expansion strategy, reflecting the Amazon platform’s authoritative recognition of Park Ha Biological’s overall brand strength, core product competitiveness, and standardized operational excellence. As the world's lead

    7/6/26 2:15:00 PM ET
    $BYAH
    $PHH
    Package Goods/Cosmetics
    Consumer Discretionary

    Park Ha Biological Technology Co., Ltd. Announces Membership Application to Personal Care Products Council (PCPC), Aligning the Brand with International Standards and Marking a Strategic Milestone in its Expansion into Amazon North America

    Wuxi, China, July 01, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) ("Park Ha Biological" or the "Company") announced that it has formally filed a complete membership application with the Personal Care Products Council (PCPC). The submission encompasses all requisite corporate qualifications, raw material compliance documentation, and product safety materials, all of which are currently under review. This application marks a pivotal step in establishing the Company’s comprehensive compliance framework for the North American market, facilitating its planned entry into Amazon’s North America marketplace, and securing access to the technical, regulatory, and i

    7/1/26 8:00:00 AM ET
    $BYAH
    $PHH
    Package Goods/Cosmetics
    Consumer Discretionary

    Park Ha Biological Technology Co., Ltd. Announces Cooperation with Amazon to Support Its Entry into the North American Personal Care Sector and Accelerate the Implementation of Its Global Strategy

    Wuxi, China, June 29, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) ("Park Ha Biological" or the "Company") announced significant progress in its global expansion by initiating cooperation with Amazon ("Amazon") North America and commencing full-scale preparations for entry into the North American personal care market, marking a key step toward the implementation of its overseas online business. Currently, four key tasks are advancing concurrently: store qualification registration, Amazon brand registry enrollment, establishment of a compliance framework for the North American market, and planning of localized product operation strategies. All preparatory e

    6/29/26 10:14:05 AM ET
    $BYAH
    $PHH
    Package Goods/Cosmetics
    Consumer Discretionary

    $BYAH
    SEC Filings

    View All

    SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.

    6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

    7/13/26 7:47:39 AM ET
    $BYAH
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.

    6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

    7/6/26 2:25:41 PM ET
    $BYAH
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.

    6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)

    7/6/26 11:42:41 AM ET
    $BYAH
    Package Goods/Cosmetics
    Consumer Discretionary